Mohammed Elfatih Hamida

Dr. Mohammed Elfatih Hamida

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2025 in Discover Medicine
Verified
Journal Article
Open access
PDF file
Nooh Mohamed HajhamedNooh Mohamed Hajhamed
Nooh Mohamed Hajhamed
NMNouh Saad Mohamed
Nouh Saad Mohamed
AAAbualgasim Elgaili Abdalla
Abualgasim Elgaili Abdalla
REReem Mohamed Ahmed Ebrahim
Reem Mohamed Ahmed Ebrahim
SMSalahaldeen Ismail Mohammed
Salahaldeen Ismail Mohammed
MSMohammed A. Salim
Mohammed A. Salim
The meteoric rise of antimicrobial resistance (AMR), marked by decreased antibiotic effectiveness against pathogenic bacteria, has sparked widespread concern. This phenomenon increases potential threats to public health by significantly hampering the clinical use of currently available antimicrobial agents, such as macrolides, β-lactam and glycopeptides antibiotics. Staphylococcus aureus (S. aureus), namely the Methicillin-Resistant Staphylococcus aureus (MRSA), is a common opportunistic pathogen that causes various types of infections and has become one of the top healthcare problems, particularly in low-income countries. In light of bacterial evolution and the unintentional use of antibiotics for medical purposes in communities and hospitals, as well as in agriculture and livestock for non-medical purposes. These events have contributed to the development and spread of antimicrobial resistance. Furthermore, resistant to our most muscular treatments against invasive S. aureus infections, such as vancomycin, is no longer successful due to the emergence of Vancomycin-Resistant S. aureus (VRSA). The scientific community is looking for creative and spectacularly effective strategies to address this global issue in response to this pandemic threat generated by the spread of antimicrobial resistance strains, with the threat of limited treatment choices against S. aureus. In this review, we highlighted the molecular mechanisms of antibiotic resistance and explained the antibiotic resistance profile of Methicillin-resistant S. aureus. On the other hand, we discuss distinguished tactics for manipulating S. aureus resistance mechanisms, such as the discovery of new chemical entities that possess antimicrobial activity with novel mechanisms of action, utilization of combinatorial antibiotic therapies, chemical derivatization and repurposing of existing known drugs to improve their antibacterial efficacy, design novel vaccine for S. aureus, antimicrobial peptides and nanoparticles as a magic bullet, and finally, by implementing the One Health Agenda against S. aureus, this holistic strategy seeks to address the spread of antibiotic resistance across the interrelated health loop of human, animals, and environments.

13 September 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
SMSamuel Tekle Mengistu
Samuel Tekle Mengistu
OAOliver Okoth Achila
Oliver Okoth Achila
ATAsmerom Tesfagiorgis Tewelde
Asmerom Tesfagiorgis Tewelde
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
FTFreweini Tekle
Freweini Tekle
WWWintana Yebio Werke
Wintana Yebio Werke
Background: Despite the outstanding measles vaccine coverage (MVC) in Eritrea, sporadic outbreaks are not uncommon. Therefore, understanding the incidence of laboratory-confirmed measles virus cases, related factors, and spatial inequalities in testing and surveillance remains crucial. In this analysis, we evaluated the incidence and spatiotemporal distribution of measles in Eritrea. An evaluation of the factors associated with measles vaccination and IgM positive (+) febrile rash was also undertaken.Methods: A retrospective (period: 2002–2020) study was carried out by abstracting data from the integrated disease surveillance and response database (IDSR). Data was analyzed using descriptive statistics and binary logistic regression. Spatial variability and distribution of confirmed cases was evaluated using ArcGIS Pro version 3.0.1.Results: In total, 9,111 suspected cases, 2,767 [1,431 (51.7%) females] were serologically tested. The median (IQR) age, minimum-maximum age were 7 years (IQR: 4–14 years) and 1 month-97 years, respectively. Among the 608(21.9%) laboratory-confirmed cases, 534 (87.8%) were unvaccinated and 53 (9.92%) were < 1 year old. The crude incidence rate for MV was 14/100,000 persons. The age-specific positivity rate per 100,000 suspected cases tested was 21.5 with individuals >30 years presenting with the highest rates (69.9/100,000). Higher odds (OR) of MV test positivity was associated with age at onset – higher in the following age-bands [10–14 years: OR = 1.6 (95%CI, 1.1–2.2, value of p = 0.005); 15–29 years: OR = 7.0 (95%CI, 5.3–9.2, value of p = 0.005); and > =30 years: OR = 16.7 (95%CI, 11.7–24) p < 0.001]. Other associations included: Address – higher in Anseba (OR = 2.3, 95%CI: 1.7–3.1, value of p<0.001); Debub (OR = 2.7, 95%CI: 1.9–3.9, value of p < 0.001); Gash-Barka (OR = 15.4, 95%CI: 10.9–21.7, value of p < 0.001); Northern Red Sea (OR = 11.8, 95%CI: 8.5–16.2, value of p < 0.001); and Southern Red Sea (OR = 14.4, 95%CI: 8.2–25.2, value of p < 0.001). Further, test positivity was higher in health centers (OR = 2.5, 95%CI: 1.9–3.4, value of p < 0.001) and hospitals (OR = 6.8, 95%CI: 5.1–9.1, value of p < 0.001). Additional factors included vaccination status - higher in the unvaccinated (OR = 14.7, 95%CI: 11.4–19.1, value of p < 0.001); and year of onset of rash – (higher >2015: OR = 1.4, 95%CI: 1.1–1.7, value of p<0.001). Uptake of measles vaccine associated with a similar complement of factors.Conclusion: In large part, efforts to eliminate measles in Eritrea are hindered by disparities in vaccine coverage, under-surveillance, and low vaccination rates in neighboring countries. Enhanced surveillance and regional micro planning targeting hard-to-reach areas can be an effective strategy to improve measles elimination efforts in Eritrea.

1 July 2022 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
SMSamuel Tekle Mengistu
Samuel Tekle Mengistu
GGGhirmay Ghebrekidan Ghebremeskel
Ghirmay Ghebrekidan Ghebremeskel
ARAron Rezene
Aron Rezene
MIMahmud Mohammed Idris
Mahmud Mohammed Idris
TTTsegereda Gebrehiwot Tikue
Tsegereda Gebrehiwot Tikue
OAOliver Okoth Achila
Oliver Okoth Achila
Background Reducing attrition in paediatric HIV-positive patients using combined antiretroviral therapy (cART) programmes in sub-Saharan Africa is a challenge. This study explored the rates and predictors of attrition in children started on cART in Asmara, Eritrea. Methods This was a retrospective cohort study using data from all paediatric patients on cART between 2005 and 2020, conducted at the Orotta National Referral and Teaching Hospital. Kaplan-Meier estimates of the likelihood of attrition and multivariate Cox proportional hazards models were used to assess the factors associated with attrition. All p values were two sided and p2015: AHR=6.1, 95% CI: 3 to 12.2), WHO body mass index-for-age z-score <−2 (AHR=1.4, 95% CI: 0.9 to 2.1), advanced HIV disease (WHO III or IV) at enrolment (AHR=2.2, 95% CI: 1.2 to 3.9), and initiation of zidovudine+lamivudine or other cART backbones (unadjusted HR (UHR)=2, 95% CI: 1.2 to 3.2). In contrast, a reduced likelihood of attrition was observed in children with a record of cART changes (UHR=0.2, 95% CI: 0.15 to 0.4). Conclusion A low incidence of attrition was observed in this study. However, the high mortality rate in the first 24 months of treatment and late presentation are concerning. Therefore, data-driven interventions for improving programme quality and outcomes should be prioritised.

26 February 2021 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
EGEyob Yohannes Garoy
Eyob Yohannes Garoy
YGYacob Berhane Gebreab
Yacob Berhane Gebreab
OAOliver Okoth Achila
Oliver Okoth Achila
NTNobiel Tecklebrhan
Nobiel Tecklebrhan
HTHermon Michael Tsegai
Hermon Michael Tsegai
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
Background. The World Health Organization has emphasized the importance of understanding the epidemiology of MDR organisms from a local standpoint. Here, we report on a spectrum of bacteria associated with surgical site infections in two referral hospitals in Eritrea and the associated antibiotic susceptibility patterns. Methods. This survey was conducted between February and May 2017. A total of 83 patients receiving treatment for various surgical conditions were included. Swabs from infected surgical sites were collected using Levine technique and processed using standard microbiological procedures. In vitro antimicrobial susceptibility testing was performed on MuellerHinton Agar by the Kirby-Bauer disk diffusion method following Clinical and Laboratory Standards Institute guidelines. The data were analyzed using SPSS version 20. Results. A total of 116 isolates were recovered from 83 patients. In total, 67 (58) and 49 (42) of the isolates were Gram-positive and Gram-negative bacteria, respectively. The most common isolates included Citrobacter spp., Klebsiella spp., Escherichia coli, Proteus spp., Pseudomonas aeruginosa, Salmonella spp., Enterobacter spp., and Acinetobacter spp. In contrast, Staphylococcus aureus, CONS, and Streptococcus viridians were the predominant Gram-positive isolates. All the Staphylococcus aureus isolates were resistant to penicillin. MRSA phenotype was observed in 70 of the isolates. Vancomycin, clindamycin, and erythromycin resistance were observed in 60, 25, and 25 of the isolates, respectively. Furthermore, a high proportion (91) of the Gram-negative bacteria were resistant to ampicillin and 100 of the Pseudomonas aeruginosa and Escherichia coli isolates were resistant to >5 of the tested antibiotics. The two Acinetobacter isolates were resistant to >7 antimicrobial agents. We also noted that 4 (60) of the Klebsiella isolates were resistant to >5 antimicrobial agents. Possible pan-drug-resistant (PDR) strains were also isolated. Conclusion. Due to the high frequency of MDR isolates reported in this study, the development and implementation of suitable infection control policies and guidelines is imperative.

31 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
SRSaud Mohammed Raja
Saud Mohammed Raja
YPYodahi Petros
Yodahi Petros
MWMunir Wahab
Munir Wahab
YSYemane Seyoum
Yemane Seyoum
FTFreweini Tekle
Freweini Tekle
Eritrea is an East African multiethnic country with an intermediate endemicity for hepatitis B. Our aim was to establish the most prevalent genotypes of hepatitis B virus (HBV) among patients with liver disease. A total of 293 Eritrean patients with liver disease who were hepatitis B surface antigen (HBsAg) positive were enrolled. All sera were tested for liver transaminases, HBV DNA viral load, and hepatitis B seromarkers including HBsAg, anti-HBcAb (total), HBeAg, and anti-HBeAb. Those reactive for HBsAg and anti-HBc (total) were further tested for HBV genotyping. The median (interquartile range) of HBV DNA viral load and ALT levels were 3.47 (1.66) log IU/mL and 28 (15.3) IU/L, respectively. Using type-specific primer-based genotyping method, 122/293 (41.6%) could be genotyped. Irrespective of mode of occurrence, HBV genotype D (21.3%) was the predominant circulating genotype, followed by genotypes C (17.2%), E (15.6%), C/D (13.1%), and C/E (10.7%). Genotypes C/D/E (7.4%), A/D (4.9%), D/E (4.1%), A (2.5%), and B, A/E, B/E, and A/D/C (0.8%) were also present. HBV in Eritrea is comprised of a mixture of HBV genotypes. This is the first study of HBV genotyping among patients with liver disease in Eritrea.

28 March 2024 in BioMed Research International
Verified
Journal Article
Open access
PDF file
KHKhalid Hussein
Khalid Hussein
BTBerhe Tesfai
Berhe Tesfai
OFOkbu Frezgi
Okbu Frezgi
HHHagos Hayelom
Hagos Hayelom
YGYosan Gebremeskel
Yosan Gebremeskel
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
Background. Antimicrobial resistance poses a significant global threat to the treatment of bacterial infections, particularly in low- and middle-income regions such as Africa. This study is aimed at analyzing antimicrobial resistance patterns in vaginal swab samples from patients at the National Health Laboratory from 2019 to 2022. Methods. This retrospective study examined patient records from vaginal swab analyses performed at the National Health Laboratory between January 1, 2019, and December 31, 2022. Ethical approval was obtained from the Ministry of Health Research Ethical Approval and Clearance Committee on 15/02/2023. Results. Of the 622 samples, 83 underwent microbial isolation and identification. Citrobacter spp. exhibited high resistance (43) to antibiotics such as cephalexin, ceftazidime, nalidixic acid, ampicillin, gentamicin, and tetracycline. E. coli showed resistance rates of more than 50 to ampicillin, trimethoprim-sulfamethoxazole, and tetracycline. Klebsiella spp. and Proteus spp. exhibited resistance rates that exceeded 47 to specific antibiotics. Gram-positive bacteria have resistance rates of more than 49 with ampicillin, trimethoprim-sulfamethoxazole, tetracycline, oxacillin, vancomycin, and penicillin G. In particular, S. aureus demonstrated no resistance to rifampicin or clindamycin, while Streptococcus spp. showed 100 resistance to rifampicin and vancomycin. Several species, including Proteus species, Streptococcus spp., S. aureus, and Klebsiella spp. exhibited multidrug resistance. Conclusion. Most gram-negative bacteria displayed higher resistance of 45 to ampicillin, trimethoprim-sulfamethoxazole, and tetracycline. Among gram-positive bacteria, a higher resistance rate with ampicillin, trimethoprim-sulfamethoxazole, tetracycline, oxacillin, vancomycin, and penicillin G was recorded. S. aureus showed no resistance to rifampicin and clindamycin, and Strep. spp. indicated 100 resistance to rifampicin and vancomycin. This study highlights critical gaps and areas for further exploration. Expanding the spectrum of antibiotics tested and investigating underlying multidrug resistance mechanisms would provide a more comprehensive understanding of resistance patterns.